In conclusion, our pediatric study shows a strong inverse association between FGF21 and FGF19 circulating levels, hepatic Klotho expression and the NAFLD severity suggesting a potential role for FGFs in the pathogenesis of NAFLD. The gene discussed is FGF19; the disease is metabolic dysfunction-associated steatotic liver disease.